TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ABSI

Absci Corp

Healthcare · Biotechnology

9.70$ -9.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ABSI
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
209.3% 239.5% 932.4% 1,025.0% 831.9% 1,377.6% 419.4%
100.0% -139.5% -832.4% -925.0% -731.9% -1,277.6% -319.4%
209.3% 239.5% 932.4% 1,025.0% 840.6% 1,408.4% 2,907.8%
171.0% 115.1% 601.8% 705.6% 634.1% 797.8% 1,252.1%
404.1% 138.8% 741.0% 932.5% 1,288.3% 1,124.0% 4,134.9%
-304.1% -278.3% -1,573.4% -1,857.5% -2,020.2% -2,401.6% -4,454.2%
13.0% 13.3% 71.8% 16.9% 17.7% 12.5% 7.5%
-319.6% -300.3% -2,297.3% -1,833.4% -1,931.9% -2,272.5% -4,111.2%
10.5% 4.5% -186.1% -8.0% 1.7% 1.5% 2.5%
-319.6% -300.3% -2,111.3% -1,825.4% -1,933.6% -2,274.1% -4,113.7%
-282.8% -263.3% -1,415.4% -1,589.6% -1,393.5% -2,075.4% -3,684.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?